Working with mice, hamsters, and nonhuman primates, Penn researchers found that a modified version of the mRNA COVID-19 ...

The researchers found that the primary composite reactogenicity outcome was noninferior in the simultaneous vs the sequential group. (HealthDay News) — Reactogenicity is comparable for simultaneous ...

Este artículo estará disponible en español en El Tiempo Latino. An abundance of evidence indicates the mRNA COVID-19 vaccines ...

The authors said the main outcomes of the study were reactogenicity, including fever, chills, muscle aches, and/or joint pain ...

Southwest District Health ended its COVID-19 vaccination program. Others in Texas, Florida and Michigan also pushed back against the vaccine.

Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...

The optimal time to get your seasonal flu shot, according to the Food and Drug Administration (FDA), is right now: flu ...

The Supreme Court hasn’t released any opinions during its current term, and none of its decisions since the pandemic match ...

The top-line beat was led by its higher than anticipated sales of Covid-19 vaccine, while its recently approved respiratory syncytial virus vaccine raked in just $10 ...

Dr. Ashish Jha, dean of the Brown University School of Public Health and the former White House Covid-19 response coordinator ...

Anyone with COVID-19 during the summer has some, but not full, protection against germs spreading in fall and winter.

Working with animals, Penn researchers modified the mRNA vaccine to target C. difficile, an infection that kills 30,000 in ...